|
1
|
Piscopiello M, Sessa M, Anzalone N, et al:
P2X7 receptor is expressed in human vessels and might play a role
in atherosclerosis. Int J Cardiol. 168:2863–2866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mehta N, Kaur M, Singh M, et al:
Purinergic receptor P2X7: A novel target for anti-inflammatory
therapy. Bioorg Med Chem. 22:54–88. 2014. View Article : Google Scholar
|
|
3
|
Wang LL, Wang HY and Qu P: Role and
relationships of pattern-recognition receptors in atherosclerosis
(In Chinese). Chin J Arterioscler. 20:951–955. 2012.
|
|
4
|
Jia Y, Zhou L and Li XH: Advance in the
study of nod-like receptor protein-3 inflammasome and
atherosclerosis (In Chinese). Chin J Arterioscler. 22:79–84.
2014.
|
|
5
|
Yang CS, Shin DM and Jo EK: The role of
NLR-related protein 3 inflammasome in host defense and inflammatory
diseases. Int Neurourol J. 16:2–12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grebe A and Latz E: Cholesterol crystals
and inflammation. Curr Rheumatol Rep. 15:3132013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duewell P, Kono H, Rayner KJ, et al: NLRP3
inflammasomes are required for atherogenesis and activated by
cholesterol crystals. Nature. 464:1357–1361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rajamäki K, Lappalainen J, Oörni K, et al:
Cholesterol crystals activate the NLRP3 inflammasome in human
macrophages: a novel link between cholesterol metabolism and
inflammation. PLoS One. 5:e117652010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Riteau N, Baron L, Villeret B, et al: ATP
release and purinergic signaling: a common pathway for
particle-mediated inflammasome activation. Cell Death Dis.
3:e4032012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niemi K, Teirilä L, Lappalainen J, et al:
Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor
and a cathepsin B-sensitive pathway. J Immunol. 186:6119–6128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eklund KK, Niemi K and Kovanen PT: Immune
functions of serum amyloid A. Crit Rev Immunol. 32:335–348. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gicquel T, Victoni T, Fautrel A, et al:
Involvement of purinergic receptors and NOD-like receptor-family
protein 3-inflammasome pathway in the adenosine
triphosphate-induced cytokine release from macrophages. Clin Exp
Pharmacol Physiol. 41:279–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gombault A, Baron L and Couillin I: ATP
release and purinergic signaling in NLRP3 inflammasome activation.
Front Immunol. 3:4142013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuroda E, Ishii KJ, Uematsu S, et al:
Silica crystals and aluminum salts regulate the production of
prostaglandin in macrophages via NALP3 inflammasome-independent
mechanisms. Immunity. 34:514–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hornung V, Bauernfeind F, Halle A, et al:
Silica crystals and aluminum salts activate the NALP3 inflammasome
through phagosomal destabilization. Nat Immunol. 9:847–856. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tschopp J and Schroder K: NLRP3
inflammasome activation: The convergence of multiple signalling
pathways on ROS production? Nat Rev Immunol. 10:210–215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Latz E, Xiao TS and Stutz A: Activation
and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wen H, Miao EA and Ting JP: Mechanisms of
NOD-like receptor-associated inflammasome activation. Immunity.
39:432–441. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McGettrick AF and O’Neill LA: How
metabolism generates signals during innate immunity and
inflammation. J Biol Chem. 288:22893–22898. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masters SL, Dunne A, Subramanian SL, et
al: Activation of the NLRP3 inflammasome by islet amyloid
polypeptide provides a mechanism for enhanced IL-1β in type 2
diabetes. Nat Immunol. 11:897–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chávez-Sánchez L, Garza-Reyes MG,
Espinosa-Luna JE, Chávez-Rueda K, Legorreta-Haquet MV and
Blanco-Favela F: The role of TLR2, TLR4 and CD36 in macrophage
activation and foam cell formation in response to oxLDL in humans.
Hum Immunol. 75:322–329. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Björkbacka H, Kunjathoor VV, Moore KJ, et
al: Reduced atherosclerosis in MyD88-null mice links elevated serum
cholesterol levels to activation of innate immunity signaling
pathways. Nat Med. 10:416–421. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
West XZ, Malinin NL, Merkulova AA, et al:
Oxidative stress induces angiogenesis by activating TLR2 with novel
endogenous ligands. Nature. 467:972–976. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miller YI, Viriyakosol S, Binder CJ,
Feramisco JR, Kirkland TN and Witztum JL: Minimally modified LDL
binds to CD14, induces macrophage spreading via TLR4/MD-2, and
inhibits phagocytosis of apoptotic cells. J Biol Chem.
278:1561–1568. 2003. View Article : Google Scholar
|
|
25
|
Mullick AE, Tobias PS and Curtiss LK:
Modulation of atherosclerosis in mice by Toll-like receptor 2. J
Clin Invest. 115:3149–3156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chávez-Sánchez L, Chávez-Rueda K,
Legorreta-Haquet MV, et al: The activation of CD14, TLR4, and TLR2
by mmLDL induces IL-1β, IL-6, and IL-10 secretion in human
monocytes and macrophages. Lipids Health Dis. 9:1172010. View Article : Google Scholar
|
|
27
|
Wiley JS, Sluyter R, Gu BJ, Stokes L and
Fuller SJ: The human P2X7 receptor and its role in innate immunity.
Tissue Antigens. 78:321–332. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benetti E, Chiazza F, Patel NS and Collino
M: The NLRP3 Inflammasome as a novel player of the intercellular
crosstalk in metabolic disorders. Mediators Inflamm.
2013:6786272013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Solini A, Menini S, Rossi C, et al: The
purinergic 2X7 receptor participates in renal inflammation and
injury induced by high-fat diet: possible role of NLRP3
inflammasome activation. J Pathol. 231:342–353. 2013.PubMed/NCBI
|
|
30
|
Hussen J, Düvel A, Koy M and Schuberth HJ:
Inflammasome activation in bovine monocytes by extracellular ATP
does not require the purinergic receptor P2X7. Dev Comp Immunol.
38:312–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dekali S, Divetain A, Kortulewski T, et
al: Cell cooperation and role of the P2X7 receptor in pulmonary
inflammation induced by nanoparticles. Nanotoxicology. 7:1302–1314.
2013. View Article : Google Scholar
|
|
32
|
Usui F, Shirasuna K, Kimura H, et al:
Critical role of caspase-1 in vascular inflammation and development
of atherosclerosis in Western diet-fed apolipoprotein E-deficient
mice. Biochem Biophys Res Commun. 425:162–168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qiao Y, Wang P, Qi J, Zhang L and Gao C:
TLR-induced NF-κB activation regulates NLRP3 expression in murine
macrophages. FEBS Lett. 586:1022–1026. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsuura E, Lopez LR, Shoenfeld Y and Ames
PR: β2-glycoprotein I and oxidative inflammation in early
atherogenesis: a progression from innate to adaptive immunity?
Autoimmun Rev. 12:241–249. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin J, Shou X, Mao X, et al: Oxidized low
density lipoprotein induced caspase-1 mediated pyroptotic cell
death in macrophages: implication in lesion instability? PLoS One.
8:e621482013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ehara S, Ueda M, Naruko T, et al: Elevated
levels of oxidized low density lipoprotein show a positive
relationship with the severity of acute coronary syndromes.
Circulation. 103:1955–1960. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu B, Nakamura T, Inouye K, et al: Novel
role of PKR in inflammasome activation and HMGB1 release. Nature.
488:670–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oury C: CD36: linking lipids to the NLRP3
inflammasome, atherogenesis and atherothrombosis. Cell Mol Immunol.
11:8–10. 2014. View Article : Google Scholar :
|
|
39
|
Sheedy FJ, Grebe A, Rayner KJ, et al: CD36
coordinates NLRP3 inflammasome activation by facilitating
intracellular nucleation of soluble ligands into particulate
ligands in sterile inflammation. Nat Immunol. 14:812–820. 2013.
View Article : Google Scholar : PubMed/NCBI
|
